JOHN KIRKWOOD to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Xenograft Model Antitumor Assays.
Connection Strength
0.354
-
GZ17-6.02 kills PDX isolates of uveal melanoma. Oncotarget. 2024 May 17; 15:328-344.
Score: 0.185
-
Clinical Development of BRAF plus MEK Inhibitor Combinations. Trends Cancer. 2020 09; 6(9):797-810.
Score: 0.141
-
The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Oncotarget. 2017 Mar 07; 8(10):16367-16386.
Score: 0.028